4202301
PRONOVA® SLM100
sodium alginate solution, Mw 150-250 kDa, mannuronate monomer units ≥50 %
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
sterility
sterile (Total viable count (CFU/g))
form
powder
mol wt
Mw 150-250 kDa
composition
mannuronate monomer units, ≥50% , G/M ratio, ≤1
impurities
≤100 EU/g Endotoxins
pH
5.5-8.5 (20 °C, 1% in water)
viscosity
100-300 mPa.s, 1 % in water(20 °C)
General description
SLM-100 is made from an alginate where over 50% of the monomer units are mannuronate and is a highly purified and well-characterized sodium alginate. The molecular weight for PRONOVA SLM-100 is in the 200000 – 300000 g/mol range. The ultra low levels of endotoxins, proteins and product sterility allows for a big variety of in vitro and in vivo applications.
Application
Examples of Pronova Alginates applications include: encapsulation of living cells and therapeutic proteins for cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery and implants, wound management, and medical devices.
Legal Information
Product of Dupont Nutrition USA, Inc.
PRONOVA is a registered trademark of International N&H USA, Inc.
Disclaimer
NOT FOR USE IN HUMANS
Storage Class
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 4202301-250MG | 04065267988252 |